Nu Skin Enterprises, Inc. with ticker code (NUS) now has 4 market analysts covering the stock. The analyst consensus now points to a “Hold” rating. The range between the high price target and the low price target is between 43 and 38, calculating the average price target we have $40.25. Now with the previous closing price of $38.94 this would mean it has a potential upside of 3.4%. The 50 day moving average is now $41.52 and the 200 day moving average is $40.89. The company’s market capitalization is $1,963 million. You can visit the company website by visiting: https://www.nuskin.com
The potential market cap would be $2.029 million based on market consensus.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to see it.
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes a variety of beauty and health products worldwide. Offers skin care devices, cosmetics and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutritional skin care products. The company also offers wellness products such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system and Beauty Focus Collagen+. In addition, she is involved in the research and development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex and ageLOC brands through retail stores, website, digital platforms and independent direct sellers and dealers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
The company has a dividend yield of 3.93% with an ex-dividend date set at 2-24-2023 (DMY).
Other figures to note are a P/E ratio of 19.17, earnings per share of 44.51 and a 5.34% return on assets.